Diagnosis before treatment
Not all hair loss is androgenetic alopecia. Telogen effluvium, alopecia areata, nutritional deficiency, inflammatory scalp disease, or a hormonal cause must be ruled out. Diagnosis determines which treatments are relevant at all.
What counts as evidence-based treatment
Topical minoxidil is approved for androgenetic alopecia in men and women. Topical finasteride is approved for men with patterned hair loss; in women, use—if any—is a cautious medical decision, not routine.
PRP is not specifically approved for hair loss, but clinical reviews report improved density in some patients, especially combined with minoxidil. iPRF and combined PRP/iPRF rest on a newer research base, with reports of density improvement. Microneedling is studied mainly as an adjunct that improves penetration of active agents.
Scalp botulinum toxin appears in the literature as a complementary model for alopecia, but evidence is much weaker than for minoxidil, finasteride, and PRP. It is not first-line treatment for hair loss.
Treatments that may help
These links go to treatments offered at the clinic that are clinically relevant to this condition. The final choice is made only after personal diagnosis.
Information on this page is general and is not a substitute for medical advice, diagnosis, or a treatment plan.